REGENCY
Freely Filtered discusses REGENCY, examining the efficacy and safety of obinutuzumab in active lupus nephritis.
Modernization and the Rising Burden of IBD: New Insights From a Global Study
FDA Approves Novel Blood Test for Alzheimer’s Detection
Is Plasma Mannose-Binding Lectin a Clue to Higher VTE Risk?